Document text
Principal Investigator: Cecilia Maria Leal
Organization: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Fiscal Year: 2023
Award: $167,855
Funding agency: National Institute of General Medical Sciences
PROJECT SUMMARY
We propose the acquisition of a new image-enhanced flow cytometer (Attune CytPix) to support the research of
1R01GM143723-01A1: Endosomal escape of lipid-based nanoparticles comprising Gaussian curvature lipids.
RNA-based therapies offer significant potential for treating a variety of diseases that have a major impact on
human health. These include chronic infections, genetic disorders, specific cancers, and the current COVID-19
pandemic. Non-viral lipid-based nanoparticles (LNPs) are the primary RNA delivery vehicles approved by the
FDA and are also being evaluated in numerous clinical trials. LNPs are composed of standard phospholipids,
cholesterol, and ionizable lipids (ILs) that become protonated in acidic conditions. Similar to enveloped viruses,
LNPs exploit the endocytic pathway to gain entry into cells. The success of RNA delivery depends on the ability
of LNPs to fuse with the endosomal membrane and escape the endosome. However, the mechanisms that
govern LNP-endosome fusion remain largely unknown.
The central goal of 1R01GM143723-01A1 is to test the hypothesis that the inclusion of a new class of structural
lipids with single chains and small headgroups like glycerol monooleate onto state-of-the art LNP formulations
allows us to prescribe well-defined internal nanostructures of LNPs directly impacting their ability to fuse with
endosomal membranes and releasing RNA cargo into the cytosol.
Acquiring the new Attune CytPix equipment is vital to the progression of our project for two main reasons. Firstly,
the only flow cytometry instrument in close proximity to our primary research location is currently non-operational
due to frequent breakdowns and high user demand, resulting in prolonged periods of downtime. Secondly, the
Attune CytPix offers simultaneous high throughput flow cytometry and high resolution brightfield imaging through
acoustic focusing, which is not available with our current equipment. This feature is particularly important for
quantifying LNP cargo loading and delivery efficiency. The high-speed brightfield camera records individual
events as they pass through the flow cell, and the Attune Cytometric Software ensures that analyzed events
originate from single cells and particles rather than doublets, clumps, or debris. This capability is critical in cell
and gene therapy research, as well as other flow cytometry experiments that aim to understand the morphology
of each cell population.
Through our research, we aim to uncover novel physical insights into the endosomal escape of LNPs and
determine the optimal membrane properties of LNPs to enhance fusion in living systems. This will lead to the
development of RNA delivery vehicles that are significantly more effective in delivering their cargo.
Terms: <1-oleoyl monoglyceride><2019-nCoV vaccine><Acoustic><Acoustics><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 vaccine><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 public health crisis><COVID19 vaccine><Cancers><Cell Body><Cell Therapy><Cells><Cholesterol><Clinical Trials><Computer software><Cytosol><DNA Therapy><Development><Disease><Disorder><Drug Delivery><Drug Delivery Systems><Endosomes><Ensure><Equipment><Event><FDA approved><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Formulation><Gene Delivery><Gene Transfer Clinical><Genetic Diseases><Genetic Intervention><Goals><Grant><Health><Human><Image><Image Enhancement><Individual><Intake><Lipids><Location><Malignant Neoplasms><Malignant Tumor><Membrane><Messenger RNA><Modern Man><Morphology><Nanostructures><Non-Polyadenylated RNA><Organism><Pathway interactions><Phosphatides><Phospholipids><Population><Property><RNA><RNA Gene Products><RNA based therapeutics><RNA based therapy><RNA delivery><RNA therapy><Receptosomes><Records><Research><Research Support><Resolution><Ribonucleic Acid><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV-2 vaccine><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-CoV2 vaccine><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccine><Software><Speed><System><Testing><Therapeutic Studies><Therapy Research><Virus><Work><cell mediated therapies><cell-based therapeutic><cell-based therapy><cellular therapeutic><cellular therapy><chronic infection><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus disease 2019 vaccine><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccine><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><delivery vector><delivery vehicle><design><designing><developmental><endosome membrane><experiment><experimental research><experimental study><experiments><flow cytophotometry><gene repair therapy><gene therapy><gene-based therapy><genetic condition><genetic disorder><genetic therapy><genomic therapy><glycerol monooleate><glyceryl monooleate><glycerylmonooleate><imaging><insight><instrument><lipid based nanoparticle><lipid nanoparticle><living system><mRNA><malignancy><membrane structure><mono-oleoylglycerol><monoolein><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nano-sized structures><nano-structures><neoplasm/cancer><novel><oleic acid monoglyceride><particle><pathway><persistent infection><resolutions><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><success><therapeutic RNA><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine for novel coronavirus>